Shuyu Liu

Aug 23, 2024 | mdpi.com | Junjie Wei |Si Zhang |Shuyu Liu |Yuexia Hu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Apr 7, 2024 | acsess.onlinelibrary.wiley.com | Ming-Shun Chen |R. Paul Drake |Shuyu Liu |Ellen E. Melson

CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. REFERENCES , , , , , & (2014). Avirulence effector discovery in a plant galling and plant parasitic arthropod, the Hessian fly (Mayetiola destructor). PLoS One, 9(6), e100958. https://doi.org/10.1371/journal.pone.0100958 , , , , , , , , , & (2019). Genetic identification of loci for Hessian fly resistance in durum wheat. Molecular Breeding, 39(2), 24. https://doi.org/10.1007/s11032-019-0927-1 , , & (1990).

Apr 4, 2024 | pericles.pericles-prod.literatumonline.com | Shuyu Liu |Yi Wei |Pengye Du

Ferroptosis induction is an emerging strategy for tumor therapy. Reactive oxygen species (ROS) can induce ferroptosis but are easily consumed by overexpressed glutathione (GSH) in tumor cells. Therefore, achieving a large amount of ROS production in tumor cells without being consumed is key to efficiently inducing ferroptosis. In this study, we designed a self-amplifying ferroptosis-inducing therapeutic agent, Pd@CeO2-Fe-Co-WZB117-DSPE-PEG-FA (PCDWD), for tumor therapy.

Feb 28, 2024 | pubs.acs.org | Yang Zhang |Shuyu Liu |Yonghui Guan |Yiqing Fan

Feb 28, 2024 | dx.doi.org | Yang Zhang |Yiqing Fan |Shuyu Liu |Yonghui Guan

Antibody-based targeted therapy in cancer faces a challenge due to uneven antibody distribution in solid tumors, hindering effective drug delivery. We addressed this by developing peptide mimetics with nanomolar-range affinity for Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) using computational methods. These peptides showed both specific targeting and deep penetration in vitro and in vivo.